Neurodyn
Vancouver
About Neurodyn
Neurodyn identifies, validates, and develops bioactive for neuroprotection and the early treatment of neurological diseases. Its product pipeline comprises ND-1004, a natural product based neuro-protectant for early-stage treatment of Parkinson's disease. It was founded in 2009 and is headquartered in Vancouver, British Columbia.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $2.8M
- Last round: Series Unknown (Apr 2016)
- Website: neurodyn.ca
- Phone: (604) 684-3323
Industries & Categories
Biotechnology, Health Care, Medical, Neuroscience
Social Profiles
Canonical: https://fsome.com/organization/neurodyn-160732 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.